Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Through its distinctive mechanism of action, Anamorelin presents novel therapeutic modalities for individuals afflicted by cachexia, thereby enhancing their nutritional state and e···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：179
Fidaxomicin is indicated for the treatment of difficult Clostridioides difficile-associated diarrhea in adults and children aged 6 months and above. Fidaxomicin hastwo main differe···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：239
Anamorelin, a pharmaceutical agent, is utilized in the treatment of specific maladies through its modulation of intricate biochemical pathways within the human organism. Widely emp···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：201
Anamorelin, a prominent anti-cachexia drug utilized in the treatment of cancer patients, has seen fluctuations in its pricing due to advancements in medical technology and increase···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：180
Sotorasib, an innovative medication targeting specific genetic mutations in non-small cell lung cancer (NSCLC), has emerged as a novel option for treating this disease owing to its···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：223
Sotorasib, a small molecule inhibitor targeting the KRAS G12C gene mutation in non-small cell lung cancer (NSCLC), has garnered significant attention since its debut. Its distincti···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：228
Anamorelin is a pharmaceutical innovation crafted and manufactured by Ono, Japan, which is a therapeutic agent tailored for the treatment of cachexia induced by various diseases. T···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：149
Sotorasib, also known as AMG-510, is an orally bioavailable drug that falls under the category of selective KRAS G12C covalent inhibitors. By locking the KRAS G12C protein in an in···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：180
Sotorasib, a novel small molecule targeted therapeutic agent, presents a promising treatment avenue for patients harboring the KRAS G12C mutation. The KRAS gene plays a pivotal rol···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：235
Sotorasib, a targeted therapy medication for non-small cell lung cancer (NSCLC), is particularly effective for patients carrying the KRAS G12C mutation. By inhibiting the activity ···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：244
Sotorasib, an oral inhibitor targeting the KRAS G12C mutation, is predominantly utilized in the treatment of non-small cell lung cancer (NSCLC). Clinical trials have demonstrated t···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：158
Adlumiz exhibits a diverse array of applications within the realm of medicine, functioning as a pharmacological intervention for the management of cachexia. Pertinently, the questi···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：164
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3162024-09-07
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：92025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：232025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：242025-27-11
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended：3052025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended：2682025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended：3492024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended：2492024-24-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
